pubmed.ncbi.nlm.nih.gov

Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials - PubMed

Review

Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

James W Daily et al. J Med Food. 2016 Aug.

Abstract

Although turmeric and its curcumin-enriched extracts have been used for treating arthritis, no systematic review and meta-analysis of randomized clinical trials (RCTs) have been conducted to evaluate the strength of the research. We systemically evaluated all RCTs of turmeric extracts and curcumin for treating arthritis symptoms to elucidate the efficacy of curcuma for alleviating the symptoms of arthritis. Literature searches were conducted using 12 electronic databases, including PubMed, Embase, Cochrane Library, Korean databases, Chinese medical databases, and Indian scientific database. Search terms used were "turmeric," "curcuma," "curcumin," "arthritis," and "osteoarthritis." A pain visual analogue score (PVAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were used for the major outcomes of arthritis. Initial searches yielded 29 articles, of which 8 met specific selection criteria. Three among the included RCTs reported reduction of PVAS (mean difference: -2.04 [-2.85, -1.24]) with turmeric/curcumin in comparison with placebo (P < .00001), whereas meta-analysis of four studies showed a decrease of WOMAC with turmeric/curcumin treatment (mean difference: -15.36 [-26.9, -3.77]; P = .009). Furthermore, there was no significant mean difference in PVAS between turmeric/curcumin and pain medicine in meta-analysis of five studies. Eight RCTs included in the review exhibited low to moderate risk of bias. There was no publication bias in the meta-analysis. In conclusion, these RCTs provide scientific evidence that supports the efficacy of turmeric extract (about 1000 mg/day of curcumin) in the treatment of arthritis. However, the total number of RCTs included in the analysis, the total sample size, and the methodological quality of the primary studies were not sufficient to draw definitive conclusions. Thus, more rigorous and larger studies are needed to confirm the therapeutic efficacy of turmeric for arthritis.

Keywords: arthritis; curcuma; osteoarthritis; pain visual analogue score; systematic review; turmeric.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.

Flowchart of the selection process of the randomized clinical trials for systematic review.

<b>FIG. 2.</b>
FIG. 2.

Forest plot of the meta-analysis for the scores of arthritis severity. (A) Mean differences in PVAS between curcuma and placebo. (B) Mean differences in PVAS and WOMAC between curcuma and placebo. (C) Mean differences in PVAS and WOMAC between curcuma and pain medicine. Each study is identified by first author and year. PVAS, pain visual analogue score; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index. Color images available online at

www.liebertpub.com/jmf
<b>FIG. 3.</b>
FIG. 3.

Funnel plot of the meta-analysis for the scores of arthritis severity. (A) Three results to measure PVAS as arthritis severity between curcuma and place. (B) Four results to measure and PVAS and WOMAC as arthritis severity between curcuma and placebo. (C) Five results to measure PVAS and WOMAC as arthritis severity between curcuma and pain medicine. The hollow circles represent the studies in the meta-analysis. Color images available online at

www.liebertpub.com/jmf

Similar articles

Cited by

References

    1. Johnson VL, Hunter DJ: The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol 2014;28:5–15 - PubMed
    1. Goldring SR: Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 2003;42 Suppl 2:ii11–ii16 - PubMed
    1. Vos T, Flaxman AD, Naghavi M, et al. : Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163–2196 - PMC - PubMed
    1. Marcu KB, Otero M, Olivotto E, Borzi RM, Goldring MB: NF-kappaB signaling: Multiple angles to target OA. Curr Drug Targets 2010;11:599–613 - PMC - PubMed
    1. Suokas AK, Sagar DR, Mapp PI, Chapman V, Walsh DA: Design, study quality and evidence of analgesic efficacy in studies of drugs in models of OA pain: A systematic review and a meta-analysis. Osteoarthritis Cartilage 2014;22:1207–1223 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources